You have no items in your shopping cart.
Cart summary
CRT0066101
Catalog Number: orb2279736
| Catalog Number | orb2279736 |
|---|---|
| Category | Small Molecules |
| Description | CRT0066101 is a PRKDs inhibitor. CRT0066101 suppressed the proliferation and migration of four bladder cancer cell lines in vitro. CRT0066101 blocked tumor growth in a mouse flank xenograft model of bladder cancer. CRT0066101 treatment or PKD2 silencing arrested bladder cancer cells at the G2/M phase, the arrest being accompanied by decreases in the levels of cyclin B1, CDK1 and phospho-CDK1 (Thr161) and increases in the levels of p27Kip1 and phospho-CDK1 (Thr14/Tyr15). CRT0066101 suppresses bladder cancer growth by inhibiting PKD2 through induction of G2/M cell cycle arrest, leading to the blockade of cell cycle progression. |
| CAS Number | [956121-30-5] |
| MW | 342.8226626 |
| SMILES | C1(O)=CC=C(Cl)C=C1C1=NC(NC[C@H](N)CC)=C2C(=N1)C=CC=C2 |
| Formula | C18H19CLN4O |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
- Item 1 of 1
CRT0066101 (hydrochloride) [orb320219]
[1290629-45-6]
447.8
C18H22N6O.3HCl
10 mM * 1 mL in DMSO, 1 g, 100 mg, 250 mg CRT0066101 [orb1217428]
> 98% (HPLC)
956121-30-5
100 mg, 5 mg, 10 mg, 25 mg, 50 mg, 1 g, 500 mg, 200 mgCRT0066101 dihydrochloride(956121-30-5 free base) [orb1218367]
> 98% (HPLC)
2308510-39-4
25 mg, 50 mg, 5 mg, 10 mg, 100 mg, 1 g, 500 mg, 200 mg
Submit a review
Filter by Rating
- 5 stars
- 4 stars
- 3 stars
- 2 stars
- 1 stars
